Access cutting-edge macular degeneration treatment through this clinical trial at a research site in Campbell. Study-provided care at no cost to qualified participants.
Access macular degeneration specialists in Campbell at no cost
This study follows strict safety protocols and ethical guidelines
All study-related macular degeneration treatment provided free
This is a multi-center, randomized, double-masked, active-comparator-controlled, Phase 3 study in a broad participant population (treatment-naïve and treatment-experienced) with neovascular (wet) age-related macular degeneration (nAMD). The study will evaluate a single intravitreal (IVT) injection of Ixo-vec compared to an active comparator. The primary endpoint of this study is the mean change in best corrected visual acuity (BCVA) of Ixo-vec compared to an active comparator measured at an aver
Sponsor: Adverum Biotechnologies, Inc.
Check if you qualify for this macular degeneration clinical trial in Campbell, CA
If you're searching for macular degeneration treatment options in Campbell, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Campbell research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.